Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
|
|
Beam Therapeutics Inc. (BEAM)
|
Add to portfolio |
|
|
|
| Price: |
$82.16
| | Metrics |
| OS: |
79.2
|
M
| |
-44
|
% ROE
|
| Market cap: |
$6.51
|
B
| |
-39
|
% ROIC
|
|
Net cash:
|
$226
|
M
| |
$2.85
|
per share
|
|
EV:
|
$6.28
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
($358)
|
M
| |
|
|
| EPS |
($4.83)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Revenues | 60.9 | 51.8 | 0.0 | 0.0 | 33.9 |
| Revenue growth | 17.5% | 215916.7% | 33.3% | -99.9% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 45.7 |
| Gross profit | 60.9 | 51.8 | 0.0 | 0.0 | -11.9 |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | -35.0% |
| Selling, general and administrative | 399.4 | 444.3 | 132.8 | 75.2 | |
| General and administrative | | | | | 11.9 |
| EBIT | -260.2 | -215.6 | -256.4 | -81.5 | -45.7 |
| EBIT margin | -427.1% | -415.9% | -1068433.3% | -452766.7% | -135.0% |
| Pre-tax income | -260.2 | -370.6 | -194.6 | -78.3 | -116.7 |
| Income taxes | 3.4 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -289.1 | -370.6 | -194.6 | -78.3 | -116.7 |
| Net margin | -474.5% | -714.9% | -810800.0% | -435144.4% | -344.6% |
| |
| Diluted EPS | ($4.13) | ($5.77) | ($4.16) | ($12.09) | ($56.62) |
| Shares outstanding (diluted) | 70.0 | 64.2 | 46.7 | 6.5 | 2.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|